Julphar Insulin R (soluble human insulin, biosimilar) + Huminsulin® Normal (soluble human insulin, reference)
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 19/100
19
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus
Conditions
Diabetes Mellitus
Trial Timeline
Dec 1, 2014 → Feb 1, 2015
NCT ID
NCT02634515About Julphar Insulin R (soluble human insulin, biosimilar) + Huminsulin® Normal (soluble human insulin, reference)
Julphar Insulin R (soluble human insulin, biosimilar) + Huminsulin® Normal (soluble human insulin, reference) is a phase 1 stage product being developed by Gulf Pharmaceutical Industries for Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT02634515. Target conditions include Diabetes Mellitus.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02634515 | Phase 1 | Completed |
Competing Products
20 competing products in Diabetes Mellitus